Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.

Federal Register: February 20, 2009 (Volume 74, Number 33)

Notices

Page 7924

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr20fe09-92

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal

Regulations (CFR), this is notice that on January 8, 2009, Sigma

Aldrich Research Biochemicals, Inc., 1-3 Strathmore Road, Natick,

Massachusetts 01760-2447, made application by renewal to the Drug

Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:

Drug

Schedule

Cathinone (1235)............................ I

Methcathinone (1237)........................ I

Aminorex (1585)............................. I

Gamma Hydroxybutyric Acid (2010)............ I

Alpha-ethyltryptamine (7249)................ I

Lysergic acid diethylamide (7315)........... I

Tetrahydrocannabinols (7370)................ I 4-Bromo-2,5-dimethoxyamphetamine (7391)..... I 4-Bromo-2,5-dimethoxyphenethylamine (7392).. I 2,5-Dimethoxyamphetamine (7396)............. I 3,4-Methylenedioxyamphetamine (7400)........ I

N-Hydroxy-3,4-methylenedioxyamphetamine

I

(7402). 3,4-Methylenedioxy-N-ethylamphetamine (7404) I 3,4-Methylenedioxymethamphetamine (MDMA)

I

(7405).

Psilocybin (7437)........................... I 5-Methoxy-N,N-diisopropyltryptamine (7439).. I 1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP) I

(7470). 1-Benzylpiperazine (BZP) (7493)............. I

Heroin (9200)............................... I

Normorphine (9313).......................... I

Amphetamine (1100).......................... II

Methamphetamine (1105)...................... II

Nabilone (7379)............................. II 1-Phenylcyclohexylamine (7460).............. II

Phencyclidine (7471)........................ II

Cocaine (9041).............................. II

Codeine (9050).............................. II

Diprenorphine (9058)........................ II

Ecgonine (9180)............................. II

Levomethorphan (9210)....................... II

Levorphanol (9220).......................... II

Meperidine (9230)........................... II

Metazocine (9240)........................... II

Methadone (9250)............................ II

Morphine (9300)............................. II

Thebaine (9333)............................. II

Levo-alphacetylmethadol (9648).............. II

Carfentanil (9743).......................... II

Fentanyl (9801)............................. II

The company plans to manufacture reference standards.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of

Diversion Control, Federal Register Representative (ODL), 8701

Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than April 21, 2009.

Dated: February 13, 2009.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug

Enforcement Administration.

FR Doc. E9-3646 Filed 2-19-09; 8:45 am

BILLING CODE 4410-09-P